u/vomit_free_since

the thing that actually reduced it for me was stopping at 70% full. not a supplement, not timing, just eating less at once on day 2.

The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.

A lane is an origin, a destination, a carrier and a season. Change any one and the distribution changes, which is why supplier-level shipping averages are close to meaningless.

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

Push back: comparing headline prices across countries without normalising pack size is comparing two different quantities.

Yes — four nations, four pathways, and threads that ignore that give people the wrong answer confidently.

Disagreeing with this line: that is the arrangement in one nation and the question is about another.

Switched pharmacies mid-titration and had to restart the ladder because the concentrations did not line up.

A private prescription is an independent route: it does not affect NHS list position, and it is not a step in the same pathway.

Why the monthly pricing tracker works, and the rule that makes it work.

Members post the pharmacy, the product, the month and the price they actually paid — not an advertised offer, not a first-month discount. No links of any kind are permitted, which removes the entire incentive to post anything other than what happened.

The result is that the spread between pharmacies in a given month is visible, and it is consistently larger than people expect. That single table has saved members here more money than every other thread on the board combined, and it survives only because the no-links rule is enforced without exception.

What lead time were you quoted at checkout?

Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.

That is the first-month offer price, not the ongoing monthly cost. The tracker records the second one.

Concentrations can differ between products and between pharmacies.

Disagreeing with this line: that is the arrangement in one nation and the question is about another.

Small fix — those two prices are for different pack sizes, which accounts for most of the gap.

tier 3 waiting lists are measured in years, not months

tolerance to the gastric effect develops, appetite effect largely persists

I would not read a supply notice as a shortage in your pharmacy tomorrow. They are not the same thing.

Same view. Tolerance developing to the gastric effect while the appetite effect persists explains most of what the side-effect board reports.

no referral links, ever, and that rule is why the pricing threads work

That is Scotland’s arrangement and the post is asking about England.

I would not read a single slow shipment as a lane change. Post it and let the median move if it is real.

Which member state?

That shortage notice was national and does not apply where the question is coming from.

no tracking numbers, ever

Disagree. That is a preclinical finding in a rodent model and you are stating it as human pharmacology.

Reimbursed or private?

rigid outer packaging is the cheapest quality signal there is

an online consultation that asks you nothing is not a consultation

Adding the practical bit — ask what happens at discharge before you start, not after.

Read the MHRA notice rather than the news coverage and the actual scope was much narrower than the panic threads suggested.

Is this a discharge back to the GP, or a discontinuation?

What does the local patient information leaflet say?

Disagreeing with this bit: that criterion belongs to one member state and is being quoted as general.

Correction: that threshold is your ICB’s, not a national one. They differ and they change by year.

Posted my first lane report here without the month and got asked for it. Fair, and the table is better for the fussiness.

Was completely wrong about the gastric emptying story in a thread here two years ago.

swirl_dont_shake is right that mechanism gives direction and not magnitude. Worth pinning.

Have you seen the current threshold published by your ICB?

England, Scotland, Wales and Northern Ireland are four different pathways

private and NHS pathways are not a ladder, they are separate routes

Disagree. That is a preclinical finding in a rodent model and you are stating it as human pharmacology.

two identical orders a week apart is the cheapest experiment available